What it's for (Indications)
- Propofol is an intravenous general anesthetic and sedation agent indicated for a range of clinical applications requiring rapid onset and short duration of action.
- Its primary uses include the initiation and maintenance of general anesthesia in adults and pediatric patients three years of age and older.
- Furthermore, propofol is widely utilized for sedation of intubated, mechanically ventilated adult patients in the Intensive Care Unit (ICU) to facilitate mechanical ventilation and reduce patient discomfort.
- It is also indicated for sedation of adults and pediatric patients three years of age and older undergoing diagnostic procedures (e.
- g.
- , endoscopy, bronchoscopy) or surgical procedures, where it is often administered as part of Monitored Anesthesia Care (MAC).
- Propofol is not recommended for routine use in pediatric ICU sedation due to specific safety concerns and is not intended for chronic sedation or use outside of closely monitored settings with personnel trained in airway management.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | Propofol dosage is highly individualized and must be meticulously titrated based on the patient's age, weight, physical status, concurrent medications, and the specific procedure being performed. Administration is strictly via intravenous route, typically involving an initial bolus for induction followed by a continuous infusion for maintenance of anesthesia or sedation. Only individuals trained in the administration of general anesthesia and management of the airway should administer propofol. For induction of general anesthesia, typical adult doses range from 2.0 to 2.5 mg/kg, with lower doses often required for elderly, debilitated, or hypovolemic patients. Maintenance of general anesthesia usually involves a continuous infusion rate ranging from 100 to 200 mcg/kg/min, adjusted to anesthetic depth. For ICU sedation, initial infusion rates commonly start at 5 mcg/kg/min, titrated gradually to a desired level of sedation, typically not exceeding 50 mcg/kg/min for prolonged periods. Sedation for MAC procedures generally employs lower doses, often with small boluses followed by maintenance infusions tailored to patient response. Precise control is often achieved using an infusion pump, and strict aseptic technique must be maintained throughout administration. |
Safety & Warnings
Common Side Effects
- Propofol is associated with a spectrum of side effects, ranging from common to severe.
- Most frequently observed are cardiovascular and respiratory effects, including hypotension (often dose-dependent) and apnea, which necessitate vigilant monitoring and ventilatory support.
- Bradycardia is also a common cardiovascular effect.
- Pain on injection is frequently reported and can be mitigated by co-administration of lidocaine or injection into larger veins.
- Other common adverse effects include injection site reactions, headache, nausea, and vomiting.
- More serious, albeit less common, adverse reactions include the potentially fatal Propofol Infusion Syndrome (PRIS), characterized by metabolic acidosis, rhabdomyolysis, hyperkalemia, acute kidney failure, hepatomegaly, and cardiac failure, particularly in critically ill patients receiving high-dose, prolonged infusions.
- Anaphylaxis and other hypersensitivity reactions, although rare, can occur.
- Seizure-like movements or involuntary muscle contractions have been observed.
- Prolonged infusions can lead to hypertriglyceridemia.
- Rarely, pancreatitis and arrhythmias have been reported.
- Close monitoring of vital signs, oxygen saturation, and cardiac function is imperative during and after propofol administration.
Serious Warnings
- Black Box Warning: While Propofol (Diprivan) does not carry a formal FDA-mandated 'Black Box Warning' in its prescribing information, critical and serious safety concerns warrant significant attention, equivalent to the gravity of a boxed warning. Propofol should only be administered by persons trained in the administration of general anesthesia and not involved in the surgical/diagnostic procedure. Patients must be continuously monitored, and facilities for resuscitation, including immediate availability of equipment for airway management, supplemental oxygen, and ventilatory support, must be present. Profound respiratory depression, including apnea, and significant cardiovascular depression, leading to hypotension and bradycardia, are common and potentially life-threatening. The risk of Propofol Infusion Syndrome (PRIS), a potentially fatal syndrome characterized by severe metabolic acidosis, rhabdomyolysis, hyperkalemia, acute kidney failure, and cardiac failure, is significantly increased with prolonged, high-dose infusions, particularly in critically ill patients, children, and those with underlying mitochondrial disorders. Strict aseptic technique is critical due to the potential for bacterial contamination and subsequent infection of the lipid emulsion. Propofol has also been associated with drug abuse and dependence.
- Propofol requires extreme caution due to several significant risks.
- Profound respiratory depression, including apnea, is a common and expected effect, necessitating the immediate availability of equipment for airway management and ventilatory support.
- Significant cardiovascular depression, manifested as hypotension and bradycardia, is frequently observed, particularly in patients with compromised cardiovascular status, hypovolemia, or advanced age.
- The risk of Propofol Infusion Syndrome (PRIS) is a critical concern, especially with prolonged high-dose infusions (>4 mg/kg/hr for >48 hours) in critically ill adults, children, and those with underlying mitochondrial disorders or sepsis; close monitoring for unexplained metabolic acidosis, rhabdomyolysis, and cardiac failure is crucial.
- Due to its lipid emulsion formulation, propofol supports bacterial growth, thus strict aseptic technique for handling and administration is paramount to prevent contamination and subsequent infection.
- Neurological effects such as seizure-like movements and opisthotonos have been reported.
- Long-term infusions may result in hyperlipidemia, requiring periodic monitoring of serum triglyceride levels.
- Propofol carries potential for abuse and physical dependence.
- It is not recommended for use in obstetric procedures, for general anesthesia in pediatric patients younger than 3 years of age, or for sedation in pediatric ICU patients due to increased PRIS risk.
How it Works (Mechanism of Action)
Propofol exerts its anesthetic and sedative effects primarily through the potentiation of gamma-aminobutyric acid (GABA), the principal inhibitory neurotransmitter in the central nervous system. It binds to specific sites on the GABA-A receptor complex, thereby increasing the frequency and duration of chloride channel opening. This influx of chloride ions hyperpolarizes the neuronal membrane, reducing neuronal excitability and leading to widespread central nervous system depression. This mechanism results in a rapid onset of sedation, hypnosis, and anxiolysis. While GABA-A receptor potentiation is considered its predominant mode of action, propofol may also modulate other neurotransmitter systems and ion channels, contributing to its diverse pharmacological profile. Its high lipid solubility facilitates rapid distribution into the brain, accounting for its rapid onset of action. Subsequent rapid redistribution from the brain to other peripheral tissues leads to its short duration of action and allows for prompt awakening and recovery following discontinuation of the drug.